DOI: 10.1055/s-00000075

Seminars in Respiratory and Critical Care Medicine

References

Russell JA, Vincent JL, Kjølbye AL. , et al.
Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients.

Crit Care 2017;
21 (01) 213

Download Bibliographical Data

Access:
Access: